MOH — authorised 11 August 2004
- Marketing authorisation holder: HAMELN PHARMA PLUS
- Status: likely_approved
🇮🇱 Pentetate Calcium Trisodium in Israel
MOH authorised Pentetate Calcium Trisodium on 11 August 2004
Marketing authorisation
Pentetate Calcium Trisodium in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in Israel
Frequently asked questions
Is Pentetate Calcium Trisodium approved in Israel?
Yes. MOH authorised it on 11 August 2004.
Who is the marketing authorisation holder for Pentetate Calcium Trisodium in Israel?
HAMELN PHARMA PLUS holds the Israeli marketing authorisation.